2021 HCV Appalachia Summit
Overlapping Epidemics of Hepatitis C and Substance Abuse in Appalachia
Interrelated Policy Environment of Hepatitis C and Substance Abuse in Appalachia
Intersection of Hepatitis C Infection and Substance Abuse in Appalachia
Hepatitis C Treatment for People Who Use Drugs
Medicaid Assisted Treatment for People Who Use Drugs
Harm Reduction Services
Overdose Prevention Efforts
Breakout 1 – HCV Treatment for PWUD
Breakout 2 – MAT for PWUD
Breakout 3 – Harm Reduction
Breakout 4 – Overdose Prevention
Hepatitis C Provider Network Virtual Meeting
HCV Provider Network Virtual Meeting
HCV Provider Network Virtual Meeting: Special Speaker Series
HCV Provider Network Meeting
2021 Liver Cancer Conference
How Does Liver Cancer Develop?
HCC Surveillance in High Risk Liver Cancer
Role of Surgical Resection and Transplantation in HCC Management
Role of Locoregional Therapies in HCC Management
Medical Management of HCC
Radiation Therapy for HCC
State of the Art in Intrahepatic Cholangiocarcinoma Diagnosis and Treatment
Resectable/Transplantable HCC
Non-Resectable Non-Transplantable HCC and Medical and Locoregional Options
Intrahepatic Cholangiocarcinoma
The Liver Update
2021 NASH Update
Nutrition for Fatty Liver and Metabolic Health
Physical Activity for the Fatty Liver Patient
Living Donor Transplants
Pediatric NAFLD/NASH
Pediatric Nutrition
NASH Drug Development Update
Non Invasive Testing Update
Role of the Caregiver
Life After Transplant
2021 Pediatric Liver Disease Conference
Transplant Pre/Post
Top 5 Pediatric Liver Diseases
Managing the Daily Life of a Child with Liver Disease
Nutrition
2021 Rare Liver Disease Conference
Lysosomal acid lipase deficiency (LAL-D)
Importance of Nutrition in Liver Health
Primary Biliary Cholangitis & Primary Sclerosing Cholangitis
Wilson Disease
Hepatorenal Syndrome (HRS)
Alpha 1 Antitrypsin
Autoimmune Hepatitis
Pear Therapeutics & NVHR Updates
This Video Resource Library is brought to you, in part, by support from Eisai.
